GC
ARGS

Guggenheim Capital’s Argos Therapeutics, Inc. ARGS Stock Holding History

Guggenheim Capital’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,244
Closed -$4K – 2855
2017
Q4 		$4K Sell
1,244
-155
-11% -$498 ﹤0.01% 2704
2017
Q3 		$5K Buy
+1,399
New +$5K ﹤0.01% 2795